IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RAMBALDI, BENEDETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 669
EU - Europa 241
AS - Asia 139
OC - Oceania 2
AF - Africa 1
Totale 1.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 664
CN - Cina 82
UA - Ucraina 67
IT - Italia 54
DE - Germania 43
HK - Hong Kong 30
FI - Finlandia 20
SG - Singapore 18
IE - Irlanda 17
SE - Svezia 15
BE - Belgio 6
CZ - Repubblica Ceca 6
GB - Regno Unito 6
IN - India 6
CA - Canada 5
FR - Francia 3
AU - Australia 2
GR - Grecia 2
JO - Giordania 1
LV - Lettonia 1
RO - Romania 1
TH - Thailandia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.052
Salva come PNG Salva come JPEG
Città #
Fairfield 87
Chandler 62
Jacksonville 53
Ashburn 52
Ann Arbor 45
New York 42
Beijing 39
Wilmington 39
Woodbridge 38
Houston 36
Seattle 36
Princeton 34
Cambridge 30
Hong Kong 30
Helsinki 20
Dublin 17
Shanghai 16
Singapore 11
Boardman 10
Des Moines 10
Brescia 9
Brno 6
Brussels 6
Jinan 6
Bosio 5
Nanjing 5
Toronto 5
San Francisco 4
Shenyang 4
Bergamo 3
Falkenstein 3
Hebei 3
Milan 3
Pune 3
San Diego 3
Brooklyn 2
Guangzhou 2
Haikou 2
Leawood 2
Melbourne 2
Mumbai 2
Amman 1
Athens 1
Augusta 1
Boston 1
Bucharest 1
Catania 1
Centurion 1
Changsha 1
Chicago 1
Chiswick 1
Darfo 1
Hangzhou 1
Hanover 1
Hillsborough 1
Jiaxing 1
Kocaeli 1
Landshut 1
London 1
Nürnberg 1
Orange 1
Porto 1
Redwood City 1
Riga 1
Santa Clara 1
Tianjin 1
Totale 812
Salva come PNG Salva come JPEG
Nome #
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 117
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS 98
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 80
"Real-life' analysis of the role of antifungal prophylaxis in preventing invasive aspergillosis in AML patients undergoing consolidation therapy: Sorveglianza Epidemiologica Infezioni nelle Emopatie (SEIFEM) 2016 study 72
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 66
ANTI-CMV Immunoglobulins in Association with ANTI-CMV Drugs in Patients with Hematological Malignancies Submitted to Allogeneic STEM CELL Transplantation: A MULTI-Center Retrospective Experience 66
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 65
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 61
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 56
Favourable/Intermediate ELN-Risk Acute Myeloid Leukemia to Transplant or Not to Transplant First-Line? 55
Liposomal doxorubicin for the treatment of iatrogenic kaposi sarcoma following hematopoietic stem cell transplantation 54
ANTI-CMV IMMUNOGLOBULINS IN ASSOCIATION WITH ANTI-CMV DRUGS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES SUBMITTED TO ALLOGENEIC STEM CELL TRANSPLANTATION: A MULTI-CENTRE RETROSPECTIVE EXPERIENCE 51
Allogeneic transplantation for patient with myelodisplastic sindromes: a single centre experience 50
Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis 49
EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATEMENT OF ACUTE AND CHRONIC GRAFT VERSUS HOST DISEASE: A RETROSPECTIVE MULTICENTRIC ANALYSIS ON 94 PATIENTS. 48
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 47
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 43
Totale 1.078
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020240 10 1 5 17 13 16 13 16 39 63 22 25
2020/2021274 10 16 9 43 13 37 15 33 24 39 21 14
2021/2022162 12 11 2 13 12 17 5 11 5 28 9 37
2022/2023155 23 5 6 8 15 40 0 21 21 2 8 6
2023/2024211 21 3 24 8 7 59 4 5 39 0 2 39
2024/20258 8 0 0 0 0 0 0 0 0 0 0 0
Totale 1.078